Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Original Article

Volume 3, Number 3, June 2011, pages 106-110


In Vitro Activity of Carbapenems Alone and in Combination With Amikacin Against KPC-Producing Klebsiella Pneumoniae

Figure

Figure 1..
Figure 1.. Time-kill studies of carbapenems and amikacin alone and in combination against four KPC-3-producing K. pneumoniae isolates. GC: Growth control; AMK: amikacin; ETP: ertapenem; IPM: imipenem; MEM: meropenem.

Table

Table 1. Change in Colony Count (log1010 CFU/mL) at 24 Hours Compared to Initial Inoculums for KPC-3-Producing K. Pneumoniae Isolates Using Time-Kill Methodology
 
AntibioticC16C17C38C50
Synergy denoted as *.AMK: amikacin; ETP: ertapenem; IPM: imipenem; MEM: meropenem.
Growth control5.054.134.784.55
AMK1.363.752.984.23
ETP4.003.145.164.83
IPM4.023.304.504.71
MEM3.693.594.904.09
ETP + AMK1.572.813.864.45
IPM + AMK-1.48*-0.05*-2.13*-3.53*
MEM + AMK-1.71*-2.61*-3.58*-3.07*